September 27, 2024
When Jennifer Welsh, a 40-year-old from New Britain, Connecticut, visited her doctor about pain in her joints and neck, her doctor sent her to the emergency […]
September 26, 2024
TOPLINE: Older age, male sex, and seropositivity are linked to a higher risk for rheumatoid arthritis– interstitial lung disease (RA-ILD) with a usual interstitial pneumonia (UIP) […]
September 26, 2024
TOPLINE: Emapalumab (Gamifant)-containing regimens stabilize key laboratory parameters and show a high 12-month survival probability in patients with rheumatologic disease–associated hemophagocytic lymphohistiocytosis (HLH). METHODOLOGY: Researchers conducted […]
September 23, 2024
When a large rheumatology clinic in Richmond, Virginia, heard that Medicare would be reimbursing patient navigators, they decided to launch their own virtual navigator program. Blake […]
September 23, 2024
The US Food and Drug Administration has approved bimekizumab-bkzx (Bimzelx; UCB) for adult patients with active psoriatic arthritis (PsA), active nonradiographic axial spondyloarthritis (nr-axSpA) with objective […]
September 20, 2024
TOPLINE: Hypnosis reduces pain during sharp debridement of skin ulcers in patients with immune-mediated inflammatory diseases, with most patients reporting decreased pain awareness and lasting pain […]
September 20, 2024
Early use of mycophenolate mofetil (MMF), a drug used to dampen the immune system in organ transplant recipients, may reduce the risk for severe flares in […]
September 20, 2024
TOPLINE: The long-term use of muscle relaxants may benefit patients with painful spasms or cramps and neck pain, according to a systematic review of clinical studies, […]
September 19, 2024
TOPLINE: Adalimumab combined with corticosteroids was more advantageous than cyclosporine combined with corticosteroids in preventing uveitis relapse while maintaining a favorable safety profile in patients with […]